Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- FLY +21%, KRMD +18.5%, CLBT +17.8%, CURI +14.1%, CSIQ +11.8%, DGII +10.9%, CSCO +7.2%, AENT +6.9%, TATT +6%, NICE +5.9%, NOA +5.6%, NIQ +5.2%, DDS +4%, BILI +3.3%, ARX +3.2%, KEP +3%, GRAL +2.9%, SBET +2.6%, PAAS +2.4% (also increases dividend), TTEK +2.4% (also increases dividend), SBH +2.2%, SA +1.9%, NP +1.7%, ALH +1.6%, JD +1.4%, CELC +1.2%
Other news:
- MRSN +202.4% (Day One Biopharmaceuticals (DAWN) to acquire Mersana Therapeutics for upfront consideration of $25.00 per share in cash, plus potential contingent value rights cash payments of up to $30.25 per share)
- SEE +21.5% (buyout firm in talks to take co private, according to WSJ)
- ENGN +3.7% (prices $130 mln offering consisting of common shares and pre-funded warrants)
- BWAY +2.7% (receives FDA clearance of Deep TMS as adjunct therapy for major depressive disorder in adolescents aged 15 to 21)
- ATEX +2.6% (ATEX launches utility tower access product with CCI)
- ELME +2.2% (completes sale of 19 multifamily communities for $1.6 Billion)
- TFPM +1.3% (receives approval for normal course issuer bid renewal)
- MHO +0.9% (authorizes new $250 mln share repurchase program)
- ENVA +0.9% (authorizes new $400 mln share repurchase program)